Literature DB >> 29502617

Trabecular microbypass stents as minimally invasive approach after conventional glaucoma filtration surgery.

Thomas Macher1, Heike Häberle2, Juliane Wächter2, Carsten Thannhäuser2, Henning Aurich2, Duy-Thoai Pham2.   

Abstract

PURPOSE: To evaluate long-term efficacy and safety of 2 trabecular microbypass stents in patients with advanced primary open-angle glaucoma (POAG) and insufficient intraocular pressure (IOP) after previous filtration surgery.
SETTING: Vivantes Klinikum Neukölln, Augenklinik, Berlin, Germany.
DESIGN: Retrospective case series.
METHODS: Eyes with uncontrolled and advanced POAG since 2014 were assessed. All eyes previously had at least 1 filtration surgery procedure. The anatomical landmarks and configuration of the anterior chamber angle had to be identified easily. Two iStents were placed nasally into Schlemm canal.
RESULTS: The study comprised 42 patients (42 eyes); 18 eyes had 1 previous glaucoma filtration surgery. During the follow-up of 12 months, the mean IOP in cases of primary failure of filtration surgery decreased from preoperative 23.8 mm Hg ± 3.9 (SD) to 15.2 ± 2.7 mm Hg. For cases with more than 1 previous filtration surgery, the mean IOP decreased from preoperative 26.1 ± 5.7 mm Hg to 16.3 ± 3.3 mm Hg. Medications were reduced from 2.7 ± 0.9 to 2.0 ± 1.1. No intraoperative or perioperative complications occurred.
CONCLUSIONS: For eyes with previous filtration surgery and medically uncontrolled IOP, the implantation of 2 stents provided a minimally invasive and safe reduction of mean IOP to less than 18 mm Hg at 12 months. The number of medications was also reduced.
Copyright © 2018 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29502617     DOI: 10.1016/j.jcrs.2017.10.039

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  5 in total

1.  Half Minimally Invasive Strabismus Surgery (MISS): A single para-muscular approach to horizontal muscle strabismus surgery.

Authors:  Attiya Parveen; Farnaz Kauser; Abadan K Amitava; Naheed Akhtar
Journal:  Indian J Ophthalmol       Date:  2022-02       Impact factor: 1.848

2.  Prospective, Non-randomized, 36-Month Study of Second-Generation Trabecular Micro-Bypass Stents with Phacoemulsification in Eyes with Various Types of Glaucoma.

Authors:  Fritz H Hengerer; Gerd U Auffarth; Christoffer Riffel; Ina Conrad-Hengerer
Journal:  Ophthalmol Ther       Date:  2018-11-14

3.  One-Year Outcomes of Second-Generation Trabecular Micro-Bypass Stents (iStent Inject) Implantation with Cataract Surgery in Different Glaucoma Subtypes and Severities.

Authors:  Ali Salimi; Julie Lapointe; Paul Harasymowycz
Journal:  Ophthalmol Ther       Date:  2019-09-19

4.  Four-Year Outcomes of Two Second-Generation Trabecular Micro-Bypass Stents in Patients with Open-Angle Glaucoma on One Medication.

Authors:  Richard Lindstrom; Steven R Sarkisian; Richard Lewis; John Hovanesian; Lilit Voskanyan
Journal:  Clin Ophthalmol       Date:  2020-01-13

5.  iStent versus iStent inject implantation combined with phacoemulsification in open angle glaucoma.

Authors:  Wesam Shamseldin Shalaby; Sophia S Lam; Amirmohsen Arbabi; Jonathan S Myers; Marlene R Moster; Natasha N Kolomeyer; Reza Razeghinejad; Aakriti Garg Shukla; Tarek R Hussein; Tarek M Eid; Said M Shalaby; Daniel Lee
Journal:  Indian J Ophthalmol       Date:  2021-09       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.